Name: FENNEC PHARMACEUTICALS INC (FENC) Stock
Brand: FENNEC PHARMACEUTICALS INC
Rating: 5 (3 reviews)

FENC Latest News, Press Relases and Analysis

All

Press Releases

2 days ago - By: Zacks Investment Research - Mentions: URGN

Adherex Technologies Inc. (FENC) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

3 months ago - By: The Motley Fool

Fennec Q2 Sales Jump 33 Percent

3 months ago - By: The Motley Fool

Fennec (FENC) Q2 2025 Earnings Call Transcript

3 months ago - By: Zacks Investment Research - Mentions: OCS

Adherex Technologies Inc. (FENC) Reports Q2 Loss, Beats Revenue Estimates

3 months ago - By: Fennec Pharmaceuticals Inc. - Mentions: FRX.CA

Fennec Pharmaceuticals Reports Second Quarter 2025 Financial Results And Provides Business Update

3 months ago - By: Benzinga

Fennec Pharmaceuticals Earnings Preview

6 months ago - By: Zacks Investment Research - Mentions: JYNT EHC WGS

The Joint Misses Q1 Earnings Estimates on Rising Expenses

3 months ago - By: Benzinga - Mentions: BTCM DE TIC DFLI ...

Earnings Scheduled For August 14, 2025

3 months ago - By: Zacks Investment Research - Mentions: CDXS

Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates

3 months ago - By: Zacks Investment Research - Mentions: CUE

Cue Biopharma, Inc. (CUE) Reports Q2 Loss, Tops Revenue Estimates

3 months ago - By: Zacks Investment Research - Mentions: ROIV

Roivant Sciences Ltd. (ROIV) Reports Q1 Loss, Misses Revenue Estimates

3 months ago - By: Fennec Pharmaceuticals Inc. - Mentions: FRX.CA

Fennec Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 14, 2025

3 months ago - By: Zacks Investment Research - Mentions: CON

Concentra Group (CON) Matches Q2 Earnings Estimates

5 months ago - By: Fennec Pharmaceuticals Inc. - Mentions: FRX.CA

Fennec Announces Results of Annual Meeting

6 months ago - By: Zacks Investment Research - Mentions: ACHC EHC WGS

Acadia Healthcare Q1 Earnings Top Estimates on Rising Admissions

6 months ago - By: Zacks Investment Research - Mentions: BHST

Adherex Technologies Inc. (FENC) Reports Q1 Loss, Tops Revenue Estimates

6 months ago - By: Fennec Pharmaceuticals Inc. - Mentions: FRX.CA

Fennec Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

6 months ago - By: Zacks Investment Research - Mentions: CUE

Cue Biopharma, Inc. (CUE) Reports Q1 Loss, Misses Revenue Estimates

6 months ago - By: Zacks Investment Research - Mentions: ACAD

Acadia Pharmaceuticals (ACAD) Tops Q1 Earnings and Revenue Estimates (Revised)

6 months ago - By: Zacks Investment Research - Mentions: ABCL

AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Misses Revenue Estimates

6 months ago - By: Fennec Pharmaceuticals Inc. - Mentions: FRX.CA

Fennec Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025

6 months ago - By: Zacks Investment Research - Mentions: ACAD

Acadia Pharmaceuticals (ACAD) Tops Q1 Earnings and Revenue Estimates

6 months ago - By: Zacks Investment Research

Wall Street Analysts See an 113.25% Upside in Adherex Technologies (FENC): Can the Stock Really Move This High?

8 months ago - By: Fennec Pharmaceuticals Inc. - Mentions: FRX.CA

Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

8 months ago - By: Fennec Pharmaceuticals Inc. - Mentions: FRX.CA

Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2024 Financial Results on March 10, 2025

9 months ago - By: Fennec Pharmaceuticals Inc. - Mentions: FRX.CA

Fennec Pharmaceuticals Announces Commercial Launch of PEDMARQSI® In Germany

11 months ago - By: Fennec Pharmaceuticals Inc. - Mentions: FRX.CA